FDA — authorised 1 September 2020
- Application: NDA209510
- Marketing authorisation holder: ACACIA
- Indication: Manufacturing (CMC)
- Status: approved
🇺🇸 Barhemsys in United States
FDA authorised Barhemsys on 1 September 2020
Marketing authorisation
Barhemsys in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Barhemsys approved in United States?
Yes. FDA authorised it on 1 September 2020.
Who is the marketing authorisation holder for Barhemsys in United States?
ACACIA holds the US marketing authorisation.